Glenn R. Larsen

Glenn R. Larsen (board member) discloses dealings in Anika Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 4 February 2016 to 20 June 2025, the count stands at 6 filings.

Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The record was last updated on 24 June 2025 with a share grant in Anika Therapeutics, Inc. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.